This refresh
Data-driven refresh June 6, 2026. Top 5 per bucket by live Bull Rankings score across a 5188-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2515 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative authored by Groq (with Gemini and data-driven fallbacks). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. FSM — Fortuna Mining Corp. · score 98
Gold · price $8.69 · 1Y $9.99 · 5Y $14.63 · 10Y $21.70
FCF $563m C+ · Rev +39.8% A · D/E 0.11 A- · P/E 8.0x A · PEG n/a
Why now. Fortuna Mining Corp., a growth-oriented gold mining company, is currently trading at $8.69 with a low P/E of 8, indicating undervaluation. The company's 39.8% revenue growth rate and 31.1% profit margin demonstrate its ability to drive growth and maintain profitability. With an analyst consensus 1-year target of $14, there is potential for significant upside.
Moat. Fortuna Mining Corp.'s durable competitive advantage stems from its 22% ROE, which is driven by its ability to maintain a high profit margin in the gold mining sector. The company's low debt-to-equity ratio of 0.11 also provides it with financial flexibility to invest in its operations and pursue growth opportunities. As a mid-cap precious-metals miner, Fortuna benefits from diversified production geographies, which helps to mitigate risks and maintain a stable revenue stream.
Risk. The main risks facing Fortuna Mining Corp. include its high beta of 2.08, which indicates high volatility, and its reliance on the gold mining sector, which is subject to fluctuations in commodity prices. Additionally, the company's low analyst count of 1 may indicate a lack of coverage and visibility, which could impact its stock price.
Horizon. 1-3 yr $9.99 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $14.63 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $21.70 if current growth sustains into durable earnings power.
2. BTG — B2Gold Corp. · score 97
Gold · price $4.18 · 1Y $6.55 · 5Y $9.59 · 10Y $14.23
FCF $1.3b C+ · Rev +60.9% A · D/E 0.14 A- · P/E 11.0x A · PEG n/a
Why now. B2Gold Corp., a mid-cap gold miner, is set up for growth with a 60.9% revenue growth rate and a 14.8% profit margin, driven by its $1.3B in free cash flow. The company's current price of $4.18 and P/E of 11 make it an attractive investment, especially considering the analyst consensus 1-yr target of $6.55. With a debt-to-equity ratio of 0.14, BTG has a solid balance sheet to support its growth.
Moat. B2Gold Corp.'s moat stems from its ability to generate a 16.5% return on equity, driven by its diversified production geographies and low-cost operations. The company's 1.5 price-to-sales ratio indicates a reasonable valuation, and its 1.3 beta suggests a moderate level of risk. As a gold miner, BTG benefits from the inherent value of its precious metals reserves and the difficulty of replicating its production capabilities.
Risk. BTG faces risks related to its 1.3 beta, which indicates a moderate level of volatility, and its 0.14 debt-to-equity ratio, which, although low, still poses a risk if interest rates rise. Additionally, the company's 60.9% revenue growth rate may be difficult to sustain, and any decline in gold prices could negatively impact BTG's profitability.
Horizon. 1-3 yr $6.55 (analyst consensus (n=5)) — fundamentals + valuation re-rating. 5 yr $9.59 at ~18% CAGR — compounding case rests on the competitive position widening. 10 yr $14.23 if current growth sustains into durable earnings power.
3. SKYW — SkyWest, Inc. · score 91
Airlines · price $84.45 · 1Y $121.50 · 5Y $177.89 · 10Y $263.89
FCF $876m C+ · Rev +15.0% B+ · D/E 0.91 C+ · P/E 8.1x A · PEG 1.66 C+
Why now. SkyWest, Inc., a mid-cap airline, is poised for growth driven by its 15% revenue growth rate and 10.4% profit margin. With a $84.45 current price and a 8.1 P/E ratio, the company's valuation appears reasonable. The analyst consensus 1-yr target of $121.50 suggests significant upside potential.
Moat. SkyWest's moat is rooted in its 15.7% ROE, which is driven by its ability to maintain a 10.4% profit margin in a competitive airline industry. The company's 0.8 PS ratio and $876m in free cash flow also contribute to its financial resilience. As a growth-oriented airline, SkyWest's moat is further strengthened by its focus on expanding its operations and improving its services.
Risk. The main risks facing SkyWest include its 1.48 beta, which indicates a higher level of volatility, and its 0.91 debt-to-equity ratio, which may pose a challenge in times of economic downturn. Additionally, the company's 8.1 P/E ratio may be elevated, leaving limited room for error. These risks highlight the importance of careful monitoring and management to ensure the company's continued growth and success.
Horizon. 1-3 yr $121.50 (analyst consensus (n=6)) — fundamentals + valuation re-rating. 5 yr $177.89 at ~16% CAGR — compounding case rests on the competitive position widening. 10 yr $263.89 if current growth sustains into durable earnings power.
4. CALM — Cal-Maine Foods, Inc. · score 88
Farm Products · price $75.65 · 1Y $88.00 · 5Y $128.84 · 10Y $191.13
FCF $720m C+ · Rev +83.2% A · D/E n/a · P/E 5.3x A · PEG 2.20 C
Why now. Cal-Maine Foods, Inc., a leading player in the farm products sector, is poised for growth driven by its 83.2% revenue growth rate and 20.1% profit margin. With a current price of $75.65 and a 5.3 P/E ratio, the company's valuation appears reasonable. The analyst consensus 1-yr target of $88 suggests a potential upside, supported by the company's strong free cash flow of $720m.
Moat. Cal-Maine Foods' durable competitive advantage stems from its category leadership in the farm products sector, with a 25.7% ROE driven by pricing power. The company's cost advantages and efficient operations enable it to maintain a strong profit margin, which is further supported by its 1 price-to-sales ratio. This moat is likely to persist due to the company's established position in the market and the barriers to entry for new competitors.
Risk. The main risks facing Cal-Maine Foods include the potential for revenue growth deceleration, with the company's 83.2% revenue growth rate potentially normalizing over time. Additionally, the company's 0.24 beta suggests that it may be less volatile than the broader market, but still exposed to sector-specific risks. The lack of debt-to-equity data may also pose a risk, as it limits the ability to assess the company's leverage and financial flexibility.
Horizon. 1-3 yr $88.00 (analyst consensus (n=4)) — fundamentals + valuation re-rating. 5 yr $128.84 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $191.13 if current growth sustains into durable earnings power.
5. COLL — Collegium Pharmaceutical, Inc. · score 84
Drug Manufacturers - Specialty & Generic · price $33.38 · 1Y $54.33 · 5Y $79.55 · 10Y $118.01
FCF $330m C · Rev +23.6% A- · D/E 2.98 D · P/E 16.2x A- · PEG n/a
Why now. Collegium Pharmaceutical, Inc., a specialty and generic drug manufacturer, is currently trading at a $33.38 price point with a 16.2 P/E ratio, indicating a reasonable valuation. The company's 23.6% revenue growth rate and $330m in free cash flow suggest a strong growth trajectory. With an analyst consensus 1-yr target of $54.33, there is potential for significant upside.
Moat. Collegium Pharmaceutical's 24% ROE can be attributed to its ability to maintain a 9.4% profit margin, which is a result of its focused business model in the specialty and generic drug sector. The company's debt-to-equity ratio of 2.98 indicates a moderate level of leverage, but its 0.75 beta suggests a relatively low level of volatility. This combination of factors contributes to the company's competitive position in the market.
Risk. One of the primary risks facing Collegium Pharmaceutical is its 2.98 debt-to-equity ratio, which could become a concern if interest rates rise or the company experiences a decline in profitability. Additionally, the company's 16.2 P/E ratio is relatively high compared to some of its peers, which could lead to multiple compression if growth slows. The company's 0.75 beta also suggests that it may be more sensitive to market fluctuations than some investors might expect.
Horizon. 1-3 yr $54.33 (analyst consensus (n=6)) — fundamentals + valuation re-rating. 5 yr $79.55 at ~19% CAGR — compounding case rests on the competitive position widening. 10 yr $118.01 if current growth sustains into durable earnings power.
Value — quality at a discount
1. AU — AngloGold Ashanti plc · score 100
Gold · price $84.12 · 1Y $119.86 · 5Y $151.32 · 10Y $194.06
FCF $4.2b B · Rev +70.8% A · D/E 0.22 B+ · P/E 12.4x A- · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a mid-cap gold miner, offers an attractive setup with a 12.4 P/E and a 0.78 PEG ratio, indicating undervaluation given its 70.8% revenue growth rate. The company's current price of $84.12 and analyst consensus 1-yr target of $119.86 suggest a potential re-rating catalyst. With a 31.1% profit margin and $4.2B in free cash flow, AngloGold Ashanti has the financial flexibility to drive growth and returns.
Moat. AngloGold Ashanti's moat is rooted in its ability to generate high returns on equity, with an ROE of 43%, driven by its pricing power in the gold sector. The company's diversified production geographies and low debt-to-equity ratio of 0.22 also contribute to its competitive advantage. With a beta of 0.64, AngloGold Ashanti's stock price is less volatile than the broader market, reflecting its stable business model.
Risk. AngloGold Ashanti faces risks related to its debt-to-equity ratio of 0.22, which, although low, could increase if the company takes on more debt to finance growth initiatives. Additionally, the company's 70.8% revenue growth rate may not be sustainable, and a slowdown could impact its stock price. Furthermore, with a PEG ratio of 0.78, the company's valuation may be sensitive to changes in growth expectations.
Horizon. 1-3 yr $119.86 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $151.32 at ~12% CAGR — dividend + buyback compounding. 10 yr $194.06 if the moat survives secular pressure.
2. PDD — PDD Holdings Inc. · score 99
Internet Retail · price $85.07 · 1Y $120.11 · 5Y $151.63 · 10Y $194.46
FCF $15.3b A- · Rev +9.7% B · D/E 0.01 A · P/E 8.9x A · PEG 0.80 A-
Why now. PDD Holdings Inc., an internet retail company, presents an attractive setup with a current price of $85.07, a P/E of 8.9, and a revenue growth rate of 9.7%. The company's free cash flow of $15.3B and profit margin of 22.7% demonstrate its ability to generate cash and maintain profitability. With an analyst consensus 1-yr target of $120.11, there is potential for significant upside.
Moat. PDD's durable competitive advantage stems from its ability to maintain a 22.7% profit margin and generate significant free cash flow, indicating pricing power and efficient operations. The company's ROE of 23.7% suggests that it can effectively allocate capital to drive growth and returns. Additionally, PDD's debt-to-equity ratio of 0.01 provides flexibility for future investments and expansions.
Risk. PDD faces risks related to its beta of -0.03, which may indicate volatility in its stock price. Furthermore, the company's revenue growth rate of 9.7% may be subject to fluctuations in the internet retail sector. Additionally, PDD's analyst recommendation mean of 1.86 may not capture all potential risks and uncertainties associated with the company.
Horizon. 1-3 yr $120.11 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $151.63 at ~12% CAGR — dividend + buyback compounding. 10 yr $194.46 if the moat survives secular pressure.
3. ACN — Accenture plc · score 96
Information Technology Services · price $178.25 · 1Y $240.51 · 5Y $303.64 · 10Y $389.41
FCF $12.5b A- · Rev +7.4% B · D/E 0.25 B · P/E 14.6x A- · PEG 1.25 B
Why now. Accenture plc, a provider of information technology services, is currently undervalued with a 14.6 P/E ratio and a 1.25 PEG ratio, considering its 7.4% revenue growth rate and 10.6% profit margin. The company's $12.5B free cash flow and 24.8% ROE indicate a strong financial position. With an analyst consensus 1-yr target of $240.51, there is potential for re-rating.
Moat. Accenture's durable competitive advantage stems from its high 24.8% ROE, driven by pricing power from its category leadership in the information technology services sector. The company's 10.6% profit margin and $12.5B free cash flow also contribute to its moat, making it an attractive investment opportunity. The 1.07 beta indicates a relatively stable stock price, which is beneficial for long-term investors.
Risk. The main risks for Accenture plc include its 1.07 beta, which may indicate some volatility, and its 0.25 debt-to-equity ratio, which, although relatively low, may still pose a risk if interest rates rise. Additionally, the company's 14.6 P/E ratio may be considered elevated, which could lead to a correction in the stock price if growth slows down.
Horizon. 1-3 yr $240.51 (analyst consensus (n=26)) — multiple re-rating thesis requires a catalyst. 5 yr $303.64 at ~11% CAGR — dividend + buyback compounding. 10 yr $389.41 if the moat survives secular pressure.
4. ADBE — Adobe Inc. · score 96
Software - Application · price $251.44 · 1Y $329.81 · 5Y $416.38 · 10Y $533.99
FCF $10.3b A- · Rev +10.5% B · D/E 0.58 C+ · P/E 14.7x A- · PEG 0.71 A-
Why now. Adobe Inc., a software application company, is currently undervalued with a P/E of 14.7 and a PEG ratio of 0.71, indicating a potential re-rating catalyst. The company's revenue growth rate of 10.5% and profit margin of 29.5% demonstrate its ability to drive growth and maintain profitability. As a leading provider of software solutions, Adobe sells its products to a wide range of customers, including individuals, businesses, and governments, in various end markets.
Moat. Adobe's durable competitive advantage stems from its high ROE of 58.8%, which is driven by its pricing power and category leadership in the software application sector. The company's ability to maintain a high profit margin and generate significant free cash flow of $10.3B allows it to invest in its business and return value to shareholders. Additionally, Adobe's debt-to-equity ratio of 0.58 provides a stable financial foundation for the company.
Risk. One of the key risks facing Adobe is the potential for revenue deceleration, given its current growth rate of 10.5%. Additionally, the company's beta of 1.4 indicates a higher level of volatility, which may impact its stock price. Furthermore, Adobe's analyst consensus recommendation is subject to change, and any downgrade could negatively impact the stock.
Horizon. 1-3 yr $329.81 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $416.38 at ~11% CAGR — dividend + buyback compounding. 10 yr $533.99 if the moat survives secular pressure.
5. INCY — Incyte Corporation · score 96
Biotechnology · price $102.38 · 1Y $107.96 · 5Y $136.29 · 10Y $174.79
FCF $1.4b C+ · Rev +21.2% A- · D/E 0.01 A · P/E 14.5x A- · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company, is currently undervalued with a 14.5 P/E ratio and a 0.36 PEG ratio, indicating a potential for re-rating. The company's 21.2% revenue growth rate and 26.7% profit margin suggest a strong business model. With an analyst consensus 1-yr target of $107.96, there is a potential for upside.
Moat. Incyte's durable competitive advantage stems from its high 25.5% ROE, which is driven by its ability to generate significant free cash flow, with $1.4b in FCF over the past 12 months. The company's low 0.01 debt-to-equity ratio also provides a stable financial foundation, allowing it to invest in its business and return value to shareholders.
Risk. One of the key risks facing Incyte is its reliance on a few key products, which could be impacted by changes in the biotechnology sector. Additionally, the company's 0.79 beta indicates a moderate level of volatility, and its 14.5 P/E ratio is not extremely low, which could limit its upside potential. Furthermore, the company's 3.8 PS ratio is relatively high, which could indicate a potential for multiple compression.
Horizon. 1-3 yr $107.96 (analyst consensus (n=24)) — multiple re-rating thesis requires a catalyst. 5 yr $136.29 at ~6% CAGR — dividend + buyback compounding. 10 yr $174.79 if the moat survives secular pressure.
Speculative — asymmetric upside
1. BILL — BILL Holdings, Inc. · score 90
Software - Application · price $35.97 · 1Y $54.62 · 5Y $95.53 · 10Y $242.26
FCF $383m C · Rev +13.4% B+ · D/E 0.50 B · P/S 2.2x A- · PEG 0.36 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $35.97 with a 13.4% revenue growth rate and a $383m free cash flow. The company's 0.36 PEG ratio and 2.2 price-to-sales ratio indicate a potential for high-risk, high-reward investment. With an analyst consensus target of $54.62, there is a potential upside for investors.
Moat. BILL's moat lies in its ability to generate $383m in free cash flow, indicating a strong business model. The company's 0.5 debt-to-equity ratio suggests a manageable debt level, allowing for potential investments in growth initiatives. As a software application company, BILL benefits from the sector's characteristic high switching costs and potential for network effects.
Risk. The main risks for BILL include its 1.18 beta, indicating a higher volatility than the market, and its 0 profit margin, which may pose a challenge for the company's long-term sustainability. Additionally, the company's 0 return on equity may indicate a need for improvement in its operational efficiency.
Horizon. 1-3 yr $54.62 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $95.53 — requires the platform / technology to reach commercial scale. 10 yr $242.26 — return distribution heavily skewed.
2. PRCH — Porch Group, Inc. · score 90
Insurance - Property & Casualty · price $9.26 · 1Y $16.25 · 5Y $28.42 · 10Y $72.08
Rev +33.7% A · P/E n/a · ROE 64.8% A · P/B n/a · Yield 0.0% C
Why now. Porch Group, Inc. is a high-risk, high-reward play with a 33.7% revenue growth rate and a $90m free cash flow. The company operates in the Insurance - Property & Casualty sector, selling insurance products to customers. With a current price of $9.26 and an analyst consensus 1-yr target of $16.25, the setup is attractive for those willing to take on the risk. The growth rate is driven by the company's ability to expand its customer base and increase its market share.
Moat. Porch Group, Inc.'s moat is rooted in its ability to generate a high 64.8% return on equity, which is a result of its strong business model and sector economics. The company's high ROE is a testament to its pricing power and ability to maintain high profit margins in a competitive market. Additionally, the company's 2.3 price-to-sales ratio suggests that it has a strong market position and is able to maintain its pricing power.
Risk. The main risks facing Porch Group, Inc. are its high beta of 3.2, which indicates a high level of volatility, and its -3.7% profit margin, which suggests that the company is still losing money. Additionally, the company's high growth rate may not be sustainable, and any downturn in the market could have a significant impact on the company's stock price. The lack of debt-to-equity ratio and P/E ratio also makes it difficult to assess the company's financial health and valuation.
Horizon. 1-3 yr $16.25 (analyst consensus (n=8)) — catalyst-driven; binary events dominate. 5 yr $28.42 — requires the platform / technology to reach commercial scale. 10 yr $72.08 — return distribution heavily skewed.
3. WIX — Wix.com Ltd. · score 89
Software - Infrastructure · price $52.39 · 1Y $86.05 · 5Y $150.51 · 10Y $381.68
FCF $505m C+ · Rev +13.2% B+ · D/E n/a · P/S 1.1x A · PEG 0.12 A
Why now. Software - Infrastructure · market cap $2.2b. Down 73% from 52-week high of $190.93 — deep drawdown territory. Revenue growing +13%, comfortably above the S&P median. PEG 0.12 — paying under fair value for the growth rate. 19 sell-side analysts rate this a Buy with a mean 1-yr target of $86.05 (implying +64% upside).
Moat. Software economics — recurring revenue, embedded customer workflows, and high gross margin all compound the moat once a base account is won. Switching costs are the lever.
Risk. Currently unprofitable (margin -2.0%) — path to GAAP profitability is the core thesis risk. Down 73% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Software — competitive moat is durable until it isn't; watch net revenue retention, gross margin trends, and any new market entrant with a fundamentally lower price point.
Horizon. 1-3 yr $86.05 (analyst consensus (n=19)) — catalyst-driven; binary events dominate. 5 yr $150.51 — requires the platform / technology to reach commercial scale. 10 yr $381.68 — return distribution heavily skewed.
4. BHC — Bausch Health Companies Inc. · score 88
Drug Manufacturers - Specialty & Generic · price $5.37 · 1Y $7.50 · 5Y $13.12 · 10Y $33.27
FCF $1.0b C+ · Rev +6.7% C+ · D/E n/a · P/S 0.2x A · PEG 0.01 A
Why now. Drug Manufacturers - Specialty & Generic · market cap $2.0b. Down 38% from 52-week high of $8.69 — deep drawdown territory. PEG 0.01 — paying under fair value for the growth rate. 6 sell-side analysts rate this a Hold with a mean 1-yr target of $7.50 (implying +40% upside).
Moat. ROE 59% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Pharma moat is patent runway + pipeline depth — a single approved molecule funds the next generation of bets. Late-stage trials carry binary readouts that swing valuation 30%+.
Risk. Currently unprofitable (margin -11.5%) — path to GAAP profitability is the core thesis risk. Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trial-readout binary — late-stage clinical trials carry approve/reject outcomes that swing valuation 30%+; the equity is effectively a portfolio of these binary events, not a steady cash-flow business.
Horizon. 1-3 yr $7.50 (analyst consensus (n=6)) — catalyst-driven; binary events dominate. 5 yr $13.12 — requires the platform / technology to reach commercial scale. 10 yr $33.27 — return distribution heavily skewed.
5. ARRY — Array Technologies, Inc. · score 84
Solar · price $8.09 · 1Y $10.27 · 5Y $17.97 · 10Y $45.56
FCF $58m C- · Rev +40.2% A · D/E 2.85 D · P/S 1.0x A · PEG 0.94 B+
Why now. Array Technologies, Inc. (ARRY) is a speculative play in the utility-scale solar tracker market, currently unprofitable with a -5.6% profit margin, but demonstrating robust 40.2% revenue growth year-over-year. This binary setup hinges on ARRY leveraging its market position to achieve sustained profitability and convert its $58m TTM free cash flow into a higher valuation, with analysts targeting $10.27 in one year. The company sells solar tracking systems to utility-scale solar project developers, a critical component for maximizing energy capture.
Moat. ARRY's competitive advantage stems from its specialized solar tracking technology, which optimizes energy capture for large-scale solar projects, offering efficiency gains that drive customer adoption. The company's impressive 31.2% ROE, despite negative profit margins, suggests efficient capital deployment in its asset base, likely from strong operational leverage or favorable contract terms in a growing market. This indicates a degree of pricing power or cost efficiency in its niche, creating a barrier for new entrants.
Risk. Array Technologies faces significant financial risks, evidenced by a high debt-to-equity ratio of 2.85, which could constrain future growth or make it vulnerable to interest rate fluctuations. Its high beta of 1.78 indicates substantial volatility, making it a high-risk investment susceptible to broader market swings or sector-specific sentiment. Furthermore, the negative -5.6% profit margin highlights the ongoing challenge of converting strong revenue growth into sustainable earnings, a critical hurdle for this speculative name.
Horizon. 1-3 yr $10.27 (analyst consensus (n=22)) — catalyst-driven; binary events dominate. 5 yr $17.97 — requires the platform / technology to reach commercial scale. 10 yr $45.56 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.